ClearPoint Neuro (CLPT) Operating Leases (2019 - 2025)
ClearPoint Neuro (CLPT) has disclosed Operating Leases for 7 consecutive years, with $8.5 million as the latest value for Q4 2025.
- Quarterly Operating Leases rose 181.0% to $8.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.5 million through Dec 2025, up 181.0% year-over-year, with the annual reading at $8.5 million for FY2025, 181.0% up from the prior year.
- Operating Leases hit $8.5 million in Q4 2025 for ClearPoint Neuro, up from $6.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $8.5 million in Q4 2025 to a low of $1.4 million in Q1 2023.
- Historically, Operating Leases has averaged $3.2 million across 5 years, with a median of $2.9 million in 2024.
- Biggest five-year swings in Operating Leases: surged 907.94% in 2021 and later fell 25.88% in 2022.
- Year by year, Operating Leases stood at $1.9 million in 2021, then dropped by 20.99% to $1.5 million in 2022, then skyrocketed by 132.9% to $3.6 million in 2023, then dropped by 15.61% to $3.0 million in 2024, then skyrocketed by 181.0% to $8.5 million in 2025.
- Business Quant data shows Operating Leases for CLPT at $8.5 million in Q4 2025, $6.2 million in Q3 2025, and $6.3 million in Q2 2025.